Related Experiment Video
Updated: Mar 16, 2026
07:20
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
1.8K
CURRENT MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY: A REVIEW
Summary
Peripartum cardiomyopathy is a rare but serious heart condition affecting women during late pregnancy or postpartum. Management focuses on heart failure treatment and targeted therapies, with recurrence risk considered for future pregnancies.
Area of Science:
- Cardiology
- Obstetrics
- Genetics
Background:
- Peripartum cardiomyopathy (PPCM) was first described in 1971, characterized by cardiomegaly and heart failure during pregnancy or postpartum.
- It is an uncommon yet life-threatening cardiac failure with an unknown etiology.
Purpose of the Study:
- To review current concepts in the diagnosis and management of peripartum cardiomyopathy.
- To highlight diagnostic criteria and therapeutic strategies for PPCM.
Main Methods:
- Literature search conducted using PubMed, Google Scholar, and author collections.
- Review of diagnostic modalities including echocardiography, ECG, MRI, endomyocardial biopsy, and cardiac catheterization.
Main Results:
- Diagnostic echocardiographic criteria include LVEF < 45% or specific M-mode and dimension measurements.
- Treatment involves conventional heart failure pharmacotherapy and PPCM-targeted therapies, considering safety during pregnancy and lactation.
- Mechanical support and transplantation may be required in severe cases.
Conclusions:
- PPCM is a critical cardiac condition of unknown cause in late pregnancy or postpartum.
- Management prioritizes improving heart failure symptoms with conventional and targeted therapies.
- The risk of recurrence in subsequent pregnancies is a significant consideration.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
01:30Cardiomyopathy II: Dilated Cardiomyopathy
716
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
618
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
01:17Pericarditis III: Medical Management
480
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
480
01:29Cardiomyopathy VI: Nursing Management
436
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
436
01:14Myocarditis III: Medical Management
309
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309